Dual Task Performance in Community Dwelling Older Adults

May 4, 2021 updated by: AYŞE ÜNAL, Pamukkale University

The Relationship Between Cognitive and Motor Functions, and Dual Task Performance in Community Dwelling Older Adults: Gender Differences

Dual task performances may be impaired with the impairment in motor performance and cognitive functions due to aging. The aim of the present study is to investigate the gender differences in dual task performance. A total of 82 community dwelling older adults (41 males and 41 females) aged between 65 and 75 years were included in the study. Motor performance was evaluated with sit-to-stand test, the timed up and go test, 10 m walking test and cognitive functions were evaluated with Montreal Cognitive Assessment Test. Dual task performances were evaluated as motor-motor and cognitive-motor performance.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Denizli, Turkey
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 75 years (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Dual task performances may be impaired with the impairment in motor performance and cognitive functions due to aging. Because of this, we aimed to investigate the gender differences in dual task performance.

Description

Inclusion Criteria:

  • The individuals aged between 65 and 75 years, who agreed for participation, who received 8 or higher points from Hodkinson Mental test, who had no neurologic/orthopedic problems that could affect balance and walking, or communication problem were included in the study.

Exclusion Criteria:

  • The individuals who were using 3 or more medications that could affect motor and cognitive functions, and the ones who could not complete the tests were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
gender difference
dual task performance
dual task performance measurement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dual Task Performance
Time Frame: 5 minutes
Assessment of Dual Task Performance
5 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Montreal Cognitive Assessment Scale
Time Frame: 5 minutes
Assessment of Cognitive Functions
5 minutes
Timed Up and Go
Time Frame: 5 minutes
Assessment of Physical Performance
5 minutes
30 Seconds Sit-to-Stand Test
Time Frame: 5 minutes
Assessment of Physical Performance
5 minutes
10 Meter Walking Test
Time Frame: 5 minutes
Assessment of Physical Performance
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2020

Primary Completion (ACTUAL)

March 1, 2021

Study Completion (ACTUAL)

April 1, 2021

Study Registration Dates

First Submitted

May 4, 2021

First Submitted That Met QC Criteria

May 4, 2021

First Posted (ACTUAL)

May 7, 2021

Study Record Updates

Last Update Posted (ACTUAL)

May 7, 2021

Last Update Submitted That Met QC Criteria

May 4, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 60116787-020/77265

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dual Task

Clinical Trials on dual task performance

3
Subscribe